BACE1 and diabetes mellitus: found that increased plasma levels of β-Site APP-cleaving enzyme 1 (BACE1) were associated with poor overall cognition functions, especially visual/logical memory, visuospatial abilities, and executive functions in Diabetes-MCI patients (22).